Unraveling the Mysteries of Schizophrenia: Genetic Deletions Discovered in Early Gestation Raise Hope for Early Prevention

 / 

Mysteries of Schizophrenia

In the quest to comprehend the origins and mysteries of schizophrenia, a groundbreaking study led by Harvard Medical School clinician-scientist Eduardo Maury has uncovered genetic deletions associated with the disorder that likely occur during early gestation.

This discovery, based on an extensive analysis of genetic data from nearly 25,000 individuals with and without schizophrenia, adds a new dimension to the understanding of this complex neurological disorder.

Schizophrenia, affecting 1 in 300 people worldwide, typically manifests in early adulthood. The prevailing belief has been that genetic and environmental factors, such as childhood trauma or viral infections, contribute to an individual’s risk of developing the disorder.

However, recent research suggests that the physiological roots of schizophrenia may be established either in early pregnancy or due to gestational complications.

Maury and his team focused on two genes, NRXN1 and ABCB11, both exhibiting copy number variations—genetic errors involving the duplication or deletion of gene copies. Importantly, these alterations were found in utero and were not inherited from parents, challenging the conventional understanding that most cases of schizophrenia are linked to inherited genetic mutations.

NRXN1, a gene associated with brain cell signal transmission, has been implicated in schizophrenia when mutations are inherited. However, Maury’s team identified partial deletions of NRXN1 in five cases of schizophrenia, a prevalence significantly higher than in population-level databases. Notably, these deletions were not present in unaffected individuals in the control cohort.

Mysteries of Schizophrenia And Somatic Mutation

The discovery of somatic mutations—genetic changes acquired during early development or later in life—in NRXN1 challenges previous assumptions about the genetic basis of schizophrenia.

Somatic mutations, unlike germline mutations inherited from parents, are found only in a fraction of body cells, such as brain and blood cells, but not in sex cells. This raises intriguing questions about the transmission and heritability of such mutations.

The second gene, ABCB11, encodes a liver protein, and its link to schizophrenia was less certain. Nevertheless, Maury and his team found deletions within the ABCB11 gene in five cases of schizophrenia, all of whom were unresponsive to antipsychotic medications. The unexpected association with treatment-resistant schizophrenia adds a layer of complexity to our understanding of this gene’s role in the disorder.

Eduardo Maury, and Chris Walsh, a senior author, and geneticist at Boston Children’s Hospital, stressed that further research is essential to quantify the contribution of these genetic alterations to the overall genetic architecture of schizophrenia.

While the study suggests that alterations in NRXN1 and ABCB11 may play a small but significant role, the intricacies of their impact and potential therapeutic implications require additional investigation.

The findings from this study present an opportunity for a paradigm shift in schizophrenia research, opening the door to early prevention strategies. If the seeds of schizophrenia are indeed planted in early gestation, as this research suggests, it could reshape our approach to identifying and addressing risk factors before the disorder fully manifests.

As the scientific community continues to unravel the mysteries of schizophrenia, this study encourages a more nuanced understanding of the interplay between genetics and the developmental timeline of this complex neurological disorder.

With each discovery, researchers inch closer to the possibility of early interventions that could change the trajectory for individuals at risk of schizophrenia, offering hope for improved outcomes and a deeper comprehension of the intricate puzzle that is schizophrenia.


— Share —

— About the Author —

Leave a Reply

Up Next

New Study Reveals Link Between Depression, Anorexia, and Gut Microbiota

Mysteries of Schizophrenia

A recent study published in BMC Psychiatry sheds light on a potential connection between major depressive disorder (MDD), anorexia, and gut microbiota. Led by researchers at the First Hospital of Shanxi Medical University, the study suggests that individuals with both depression and anorexia exhibit distinct patterns in their gut bacteria, particularly involving the presence of a specific bacterium called Blautia.

Depression, characterized by persistent sadness and a loss of interest in daily activities, affects millions worldwide and is often accompanied by a high risk of suicide. Anorexia, marked by reduced appetite and distorted body image, commonly co-occurs with depression, complicating treatment efforts.

Gut Bacteria’s Role in Depression and Anorexia

Up Next

Beyond Chemical Imbalances: Researchers Shed Light on Social Root Causes Of Depression

Mysteries of Schizophrenia

In a recent letter to the editor published in Molecular Psychiatry, researchers led by Joanna Moncrieff present a compelling argument challenging the conventional understanding of depression. They assert that rather than being solely attributed to chemical imbalances in the brain, and discuss the social root causes of depression.

According to Moncrieff et al., the evidence for brain differences in depression is lacking, while there is substantial support for the influence of social and environmental factors on mental health.

They argue that the circumstances of life, such as stress and adversity, play a more significant role in shaping depressive symptoms than neuro

Up Next

Study Reveals Presence of Microplastics in Human Brain: Concerns Rise Over Health Implications

Mysteries of Schizophrenia

In a groundbreaking revelation, researchers from the University of New Mexico have discovered microplastics infiltrating human brain tissue, as reported in a study published in the journal Environment Health Perspectives. The study sheds light on the pervasive presence of microplastics in various organs of the body, including the kidneys, liver, and brain.

Eliseo Castillo, an associate professor leading the research, underscores the widespread distribution of microplastics in the environment, emphasizing their presence in water sources, food items, and even the air we breathe.

Previous studies have estimated that individuals ingest approximately five grams of microplastics weekly, equivalent to the weight of a credit card.

Up Next

Study Reveals Significant Genetic Link Between Treatment-Resistant Depression and Family History

Mysteries of Schizophrenia

In a groundbreaking study published in the journal JAMA Psychiatry, researchers have uncovered a substantial genetic link between treatment-resistant depression (TRD) and family history.

Led by Dr. Cheng-Ta Li, a professor of medicine at the National Yang-Ming Chiao Tung University in Taipei, Taiwan, the study utilized extensive national health insurance data to investigate the transmission of TRD across generations and its association with other psychiatric disorders.

The findings of the study are particularly significant, as they shed light on the hereditary nature of TRD and its implications for early intervention and treatment.

Up Next

FDA Clears Prescription Digital Therapeutic for Adults with Major Depressive Disorder

Mysteries of Schizophrenia

The FDA has recently cleared a groundbreaking prescription digital therapeutic, known as Rejoyn, for the treatment of major depressive disorder (MDD) symptoms in adults. This innovative therapy, developed by Otsuka Pharmaceutical Co. Ltd. in collaboration with Click Therapeutics Inc., aims to provide adjunctive care for individuals who have been prescribed antidepressants as part of clinician-managed outpatient treatment.

Rejoyn is a 6-week treatment program designed to assist individuals aged 22 years and older in regulating their emotions through a combination of clinically validated cognitive training exercises and therapeutic lessons.

The therapy utilizes digital platforms to deliver pe

Up Next

Sweet Science: How Chocolate’s Theobromine May Aid Weight Loss and Alzheimer’s Prevention

Mysteries of Schizophrenia

A recent study conducted by researchers at Zhengzhou University in China suggests that indulging in chocolate could offer various health benefits, including weight loss assistance and Alzheimer’s prevention.

Published in the Journal of Functional Foods, the study highlights the potential of a chemical compound found in chocolate called theobromine to positively impact both the body and the brain.

Theobromine, present in cocoa beans, boasts anti-inflammatory properties and is rich in antioxidants, making it beneficial for brain health. According to scientists, this compound can protect against Alzhei

Up Next

New Study Finds High Genetic Risk for Obesity May Require Over 14,500 Daily Steps

Mysteries of Schizophrenia

A recent study published in JAMA Network Open reveals a significant association between genetic risk for obesity and the amount of physical activity required to mitigate the risk.

Led by Dr. Evan Brittain, associate professor of medicine at Vanderbilt University Medical Center, the study analyzed data from 3,124 participants in the National Institutes of Health’s All of Us Research Program to explore the link between genetic predisposition to obesity and recommended step counts for reducing the genetic risk of developing the condition.

Findings from the study indicate that individuals with a higher genetic risk of obesity may need to undertake more physical activity